The Moral Limits to Federal Funding for Kidney Disease
Moskop, John C.
Hastings Center Report. 1987 Apr; 17(2): 11-15.
In the current era of cost-containment, Congress may reconsider its support for the End-Stage Renal Disease Program. Substantial reductions in funding for this program could be made by eliminating non-beneficial, marginally beneficial, and relatively inefficient modes of treatment. These measures, however, will only postpone the inevitable day when clearly beneficial treatment must be withheld.
Biomedical Technologies; Capitalism; Containment; Costs and Benefits; Disease; Economics; Evaluation; Financial Support; Government; Government Financing; Health; Health Care; Justice; Kidney Diseases; Kidneys; Life; Medicine; Organ Transplantation; Preventive Medicine; Prognosis; Public Policy; Quality of Life; Renal Dialysis; Resource Allocation; Risks and Benefits; Selection for Treatment; Transplantation; Value of Life;
Showing items related by title, author, creator and subject.